AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

MARBOFLOXACIN

4 registrations across 3 African markets— 2 active

Markets with MARBOFLOXACIN

🇿🇼Zimbabwe
2 registrations
2 active
🇺🇬Uganda
1 registration
0 active
🇿🇦South Africa
1 registration
0 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
MARBOSAN-100
SOLUTION; INJECTION
🇿🇼ZimbabweFIVET ANIMAL HEALTHactiveDec 2027
MARBODAC
PARENTERAL ORDINARY VIALS
🇺🇬UgandaZENEX ANIMAL HEALTH INDIA PRIVATE LIMITEDexpiredDec 2023
ZENIQUIN 200🇿🇦South AfricaZoetis South Africa (Pty) LtdsuspendedAug 2022
MARBODAC
SOLUTION; INJECTION
🇿🇼ZimbabweZENEX ANIMAL HEALTHactive—

MARBOFLOXACIN in Africa — Regulatory Overview

MARBOFLOXACIN is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Uganda, South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.